ClinicalTrials.gg
Not yet recruitingNCT07936370Updated Nov 13, 2026

Polygonatum Odoratum Extract Combined With Aerobic Exercise Improves Body Composition, Insulin Resistance, Inflammation and Gut Microbiota-SCFA Profiles in Men With Central Obesity

An interventional study of Supervised Aerobic Exercise and Polygonatum odoratum Extract in Central Obesity, Insulin Resistance and Inflammation, sponsored by Beijing Sport University. Not yet recruiting. Open to male participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Beijing Sport University · Not applicable, Interventional, and Basic science

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
Male
01

Study summary

This is a randomized controlled trial to investigate whether a combination of Polygonatum odoratum extract and aerobic exercise can improve body composition, insulin resistance, and inflammation in men with central obesity. Participants will be randomly assigned to either an intervention group (90 days of supervised aerobic exercise combined with daily Polygonatum odoratum extract supplementation) or a control group (usual lifestyle advice). The investigators will measure changes in body fat percentage, muscle mass, blood glucose, insulin levels, inflammatory markers, gut microbiota, and short-chain fatty acids (SCFAs) before and after the 90-day intervention. The goal is to evaluate whether combining Polygonatum odoratum supplementation with aerobic exercise can improve metabolic health in men with central obesity. Possible benefits include improved body composition and insulin sensitivity, as well as favorable changes in gut microbiota and SCFA profiles. Potential risks may include mild muscle soreness associated with exercise and gastrointestinal discomfort related to the supplement.

02

Conditions studied

  • Central Obesity
  • Insulin Resistance
  • Inflammation

Keywords

  • Aerobic Exercise
  • Insulin Resistance
  • Polygonatum odoratum
  • Inflammation
  • Body Composition
03

In context

Obesity, Abdominal

295 studies on the registry are indexed under Obesity, Abdominal; 45 are open to participants now.

This study's planned enrollment of 200 is above the median of 58 across 235 interventional studies indexed under Obesity, Abdominal.

Browse Obesity, Abdominal studies →

Lead sponsor

Beijing Sport University is the lead sponsor of 56 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chinese males aged 40 to 65 years.
  • Central obesity, defined as a waist circumference (WC) > 90 cm and a (BMI) ≥ 25.0 kg/m².
  • A daily eating window of ≥ 14 hours.
  • Moderate-to-vigorous physical activity (MVPA) ≤ 150 minutes per week.
  • Sedentary time ≥ 8 hours per day.

Exclusion criteria

Exclusion Criteria:

  • Confirmed diagnosis of cardiovascular disease (CVD) or diabetes mellitus.
  • A history of alcohol consumption or tobacco use.
  • Diagnosis of conditions (e.g., arthritis) or presence of injuries that impair gait and limit exercise capacity.
  • Participation in other clinical trials within 4 weeks prior to enrollment.
  • Use of treatments or medications that may affect appetite or metabolism.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
200 participants (estimated)

Study arms

  • No intervention
    Control Group (CON)
  • Experimental
    Polygonatum odoratum(PO)

    Dietary Supplement: Polygonatum odoratum Extract

  • Experimental
    Aerobic Exercise Training Group (ET)

    Behavioral: Supervised Aerobic Exercise

  • Experimental
    Combined Intervention Group (POET)

    Behavioral: Supervised Aerobic Exercise · Dietary Supplement: Polygonatum odoratum Extract

Interventions

  • BehavioralSupervised Aerobic Exercise

    Moderate-intensity aerobic exercise 3 times per week, 40 minutes per session, for 90 days, supervised by trained exercise professionals.

  • Dietary supplementPolygonatum odoratum Extract

    Daily oral supplementation with standardized Cistanche deserticola extract for 90 days, administered as a capsule or powder.

06

What researchers measure

Primary outcomes

  1. Waist Circumference

    Full Name of Measurement Tool:Lufkin W606PM Metallic Tape;Measurement Method:Measured in accordance with the guidelines of the International Society for the Advancement of Kinanthropometry (ISAK). The measurement site is the midpoint between the iliac crest and the lower costal margin. The subject stands with relaxed abdomen and feet together, and the measurement is repeated at least 3 times to take the average value;Measurement Unit:Centimeter (cm)

    Time frame: Baseline to 90 days

  2. Height

    Full Name of Measurement Tool:Seca Leicester Stadiometer;Measurement Method:Measured in a standard standing position, barefoot, with the back against the stadiometer and the head kept level;Measurement Unit:Centimeter (cm)

    Time frame: Baseline to 90 days

  3. Body Weight

    Full Name of Measurement Tool:Tanita MC-780 MA Bioelectrical Impedance Analysis Instrument;Measurement Method:Measured after fasting, with light clothing and empty bladder, the measurement is repeated at least 3 times to take the average value;Measurement Unit:Kilogram (kg)

    Time frame: Baseline to 90 days

  4. Body Mass Index (BMI)

    Full Name of Measurement Tool:Seca Leicester Stadiometer + Tanita MC-780 MA Bioelectrical Impedance Analysis Instrument;Measurement Method:Calculated by the formula: BMI = Body Weight (kg) / Height² (m²);Measurement Unit:Kilogram per square meter (kg/m²)

    Time frame: Baseline to 90 days

  5. Systolic Blood Pressure (SBP)

    Full Name of Measurement Tool:Omron M7 Intelli IT Automatic Blood Pressure Monitor;Measurement Method:Measured in a standard sitting position after the subject rests for 15 minutes, the measurement is repeated 3 times to take the average value;Measurement Unit:Millimeter of mercury (mmHg)

    Time frame: Baseline to 90 days

  6. Diastolic Blood Pressure (DBP)

    Full Name of Measurement Tool:Omron M7 Intelli IT Automatic Blood Pressure Monitor;Measurement Method:Measured in a standard sitting position after the subject rests for 15 minutes, the measurement is repeated 3 times to take the average value;Measurement Unit:Millimeter of mercury (mmHg)

    Time frame: Baseline to 90 days

  7. Body Fat Percentage

    Full Name of Measurement Tool:Tanita MC-780 MA Bioelectrical Impedance Analysis Instrument;Measurement Method:Measured after more than 10 hours of fasting and avoiding exercise, alcohol and caffeine for more than 4 hours. The skin electrodes are cleaned before measurement, and the measurement is repeated 3 times to take the average value;Measurement Unit:Percentage (%)

    Time frame: Baseline to 90 days

  8. Muscle Mass Percentage

    Full Name of Measurement Tool:Tanita MC-780 MA Bioelectrical Impedance Analysis Instrument;Measurement Method:Measured after more than 10 hours of fasting and avoiding exercise, alcohol and caffeine for more than 4 hours. The skin electrodes are cleaned before measurement, and the measurement is repeated 3 times to take the average value;Measurement Unit:Percentage (%)

    Time frame: Baseline to 90 days

  9. Maximal Oxygen Consumption (VO₂max)

    Full Name of Measurement Tool:Treadmill + Physio-Dyne Instrument Corp. MAX II Metabolic System + Polar H10 Heart Rate Monitor;Measurement Method:The modified Bruce protocol is adopted, the treadmill is subjected to incremental load exercise until exhaustion, and respiratory gas exchange variables and heart rate are recorded in real time;Measurement Unit:Milliliter per kilogram per minute (mL/kg/min)

    Time frame: Baseline to 90 days

Secondary outcomes

  1. Fasting Blood Glucose

    Full Name of Measurement Tool:Bayer AG Contour Plus Blood Glucose Meter;Measurement Method:Venous blood is collected after the subject fasts for 10 hours and detected immediately;Measurement Unit:Millimole per liter (mmol/L)

    Time frame: Baseline to 90 days

  2. Glycated Hemoglobin (HbA1c)

    Full Name of Measurement Tool:Roche cobas® b 101 Analyzer;Measurement Method:Venous blood is collected on an empty stomach, and serum is separated for instrument detection;Measurement Unit:Percentage (%)

    Time frame: Baseline to 90 days

  3. Fasting Insulin

    Full Name of Measurement Tool:Mercodia Uppsala Enzyme-Linked Immunosorbent Assay (ELISA) Kit;Measurement Method:Venous blood is collected on an empty stomach, plasma is separated and detected by double replicate ELISA;Measurement Unit:Milliunit per liter (mU/L)

    Time frame: Baseline to 90 days

  4. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)

    Full Name of Measurement Tool:Bayer AG Contour Plus Blood Glucose Meter + Mercodia Uppsala Enzyme-Linked Immunosorbent Assay (ELISA) Kit;Measurement Method:Calculated by the formula: HOMA-IR = (Fasting Blood Glucose × Fasting Insulin) / 22.5;Measurement Unit:No unit

    Time frame: Baseline to 90 days

  5. Homeostatic Model Assessment for Beta Cell Function (HOMA-β)

    Full Name of Measurement Tool:Bayer AG Contour Plus Blood Glucose Meter + Mercodia Uppsala Enzyme-Linked Immunosorbent Assay (ELISA) Kit;Measurement Method:Calculated by the formula: HOMA-β = (20 × Fasting Insulin) / (Fasting Blood Glucose - 3.5);Measurement Unit:No unit

    Time frame: Baseline to 90 days

  6. Total Cholesterol (TC)

    Full Name of Measurement Tool:Roche cobas® c 111 Analyzer;Measurement Method:Venous blood is collected on an empty stomach, and serum is separated for instrument detection;Measurement Unit:Millimole per liter (mmol/L)

    Time frame: Baseline to 90 days

  7. Triglycerides (TG)

    Full Name of Measurement Tool:Roche cobas® c 111 Analyzer;Measurement Method:Venous blood is collected on an empty stomach, and serum is separated for instrument detection;Measurement Unit:Millimole per liter (mmol/L)

    Time frame: Baseline to 90 days

  8. High-Density Lipoprotein (HDL)

    Full Name of Measurement Tool:Roche cobas® c 111 Analyzer;Measurement Method:Venous blood is collected on an empty stomach, and serum is separated for instrument detection;Measurement Unit:Millimole per liter (mmol/L)

    Time frame: Baseline to 90 days

  9. Low-Density Lipoprotein (LDL)

    Full Name of Measurement Tool:Roche cobas® c 111 Analyzer;Measurement Method:Venous blood is collected on an empty stomach, and serum is separated for instrument detection;Measurement Unit:Millimole per liter (mmol/L)

    Time frame: Baseline to 90 days

  10. Leptin

    Full Name of Measurement Tool:ImmunoDiagnostics Limited / Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Kit;Measurement Method:Venous blood is collected on an empty stomach, plasma is separated and detected by double replicate ELISA;Measurement Unit:Nanogram per milliliter (ng/ml)

    Time frame: Baseline to 90 days

  11. Ghrelin

    Full Name of Measurement Tool:Bio-Rad Hercules California Luminex Assay Kit;Measurement Method:Venous blood is collected on an empty stomach, plasma is separated and detected by magnetic bead-based Luminex assay;Measurement Unit:Picogram per milliliter (pg/ml)

    Time frame: Baseline to 90 days

  12. C-Reactive Protein (CRP)

    Full Name of Measurement Tool:ImmunoDiagnostics Limited / Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Kit;Measurement Method:Venous blood is collected on an empty stomach, plasma is separated and detected by double replicate ELISA;Measurement Unit:Microgram per milliliter (ug/ml)

    Time frame: Baseline to 90 days

  13. Plasminogen Activator Inhibitor-1 (PAI-1)

    Full Name of Measurement Tool:Bio-Rad Hercules California Luminex Assay Kit;Measurement Method:Venous blood is collected on an empty stomach, plasma is separated and detected by magnetic bead-based Luminex assay;Measurement Unit:Picogram per milliliter (pg/ml)

    Time frame: Baseline to 90 days

  14. Gut Microbiota Composition (Phylum/Class/Genus level)

    Full Name of Measurement Tool:Omega BIO-TEK Norcross E.Z.N.A.® Stool DNA Kit + BGI Genomics 16S/18S/ITS Amplicon Metagenomic Sequencing Platform;Measurement Method:Fecal samples are provided by subjects on an empty stomach, transported on ice within 2 hours or frozen at -80℃; microbial DNA is extracted for 16S rRNA amplicon sequencing, and taxonomic composition is analyzed by software such as DADA2 and phyloseq;Measurement Unit:Relative abundance (%) / No unit (sequencing read count)

    Time frame: Baseline to 90 days

  15. Microbial Differential Abundance (Enterocloster/Gemella)

    Full Name of Measurement Tool:BGI Genomics 16S/18S/ITS Amplicon Metagenomic Sequencing Platform + R Language (emmeans/vegan package);Measurement Method:Analyzed by Δabundance (post-intervention - pre-intervention), combined with Analysis of Covariance (ANCOVA) and Permutational Multivariate Analysis of Variance (PERMANOVA) statistical tests;Measurement Unit:No unit (standardized abundance value)

    Time frame: Baseline to 90 days

  16. Short-Chain Fatty Acids (SCFAs) Targeted Metabolomics Detection

    Full Name of Measurement Tool:Thermo ScientificTM TSQ Altis Mass Spectrometer + Thermo Scientific Vanquish TM Flex Ultra-High Performance Liquid Chromatograph + Waters ACQUITY UPLC BEH C18 Chromatographic Column;Measurement Method:Prepare SCFA standards and isotope internal standards, extract biological sample metabolites. UHPLC-MS/MS detection with gradient elution (40°C, 2μL injection, 0.3mL/min flow rate), ESI negative ion MRM mode; validate via linearity, precision, accuracy, stability and QC. Quantify with standard/internal standard ratio standard curve; conduct PCA, clustering, KEGG annotation and differential metabolite screening;Measurement Unit:nanogram per milliliter (ng/mL) / microgram per milliliter (ug/mL)

    Time frame: Baseline to 90 days

  17. Total Daily Energy Intake

    Full Name of Measurement Tool:Dietary Record(MyFitnessPal APP); trained dietitians calculate total daily energy intake using nutrient databases; compliance is assessed during study visits;Measurement Unit:Kilocalorie per day (kcal/d)

    Time frame: Baseline to 90 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 107 non-industry interventional studies with no phase under Obesity, Abdominal, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 29. This study's planned 2 months is below that.

Counting every sponsor, half of 117 studies reached it within 16 months; a quarter within 7 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2026
First posted
Nov 13, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Mar 1, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07936370
Lead sponsor
Beijing Sport University
Responsible party
Sponsor
First posted
Nov 13, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Biaoxu Tao
Contact
taobx020907@gmail.com
15797892587
Chang Liu
principal investigator · Beijing Sport University, Beijing, Beijing 100084

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion